As
an emerging cancer treatment, Ca2+-loaded nanoagents
can disorder intracellular calcium homeostasis to induce cancer cell
death. However, the developed Ca2+ nanocarriers are very
limited in variety. Herein, we developed a metal oxide based nanoagent,
Ca0.35CoO2@ss-SiO2-Ce6 (denoted as
CCO@ss-SiO2-Ce6), which not only intensively released Ca2+ but also realized enhanced photothermal and photodynamic
therapy. The excellent photothermal conversion efficacy (48.01% at
808 nm laser illumination, 1 W/cm2), high heat-enhanced
release rate of Ca2+ (50.09% at pH 4.5), and catalase-mimic
activity to generate oxygen as well as the facilitated production
of the singlet oxygen all contributed to the enhanced synergistic
cancer therapy efficacy. The in vitro and in vivo experiments displayed
that CCO@ss-SiO2-Ce6 demonstrated superior biocompatibility
and remarkable suppressive tumor growth. This work opens a pathway
for fabricating synergistic therapeutic nanoplatforms.